Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

News

CureVac, BioNTech and mRNA

Digest more
PharmTech · 2d
CureVac to Be Acquired by BioNTech in $1.25B Deal to Advance mRNA Cancer Therapies
The acquisition boosts BioNTech’s mRNA design and manufacturing capabilities, accelerating development of next-gen cancer immunotherapies.

Continue reading

 · 3d · on MSN
BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals
Fierce Biotech · 3d
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
GlobalData on MSN3d
BioNTech bolsters mRNA pipeline with $1.25bn CureVac acquisition
BioNTech has agreed to acquire mRNA specialist CureVac for approximately $1.25bn, as the big pharma company amps up its ...
PMLive2d
BioNTech expands mRNA capabilities with $1.25bn CureVac acquisition
BioNTech has announced that it will be expanding its messenger RNA (mRNA) capabilities by acquiring CureVac for approximately ...
C&EN3d
BioNTech to buy fellow German mRNA firm CureVac
The German mRNA firm BioNTech has announced that it will buy local rival CureVac in an all-stock transaction that values ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy